Skip to main content

Table 3 HSDS change from baseline stratified by age at treatment start and gender.

From: Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study

  

Male

Female

  

11 years

11 years

-value

10 years

10 years

-value

  

Mean ± SD

Mean ± SD

 

Mean ± SD

Mean ± SD

 

GHD

Year 1

759

0.75 ± 0.52

1,169

0.41 ± 0.36

.0001

272

0.78 ± 0.54

324

0.48 ± 0.40

.0001

 

Year 2

555

1.20 ± 0.68

780

0.85 ± 0.54

.0001

206

1.25 ± 0.65

214

0.91 ± 0.58

.0001

MPHD

Year 1

96

0.85 ± 1.07

45

0.27 ± 0.40

.0001

46

0.86 ± 0.82

35

0.29 ± 0.45

.0002

 

Year 2

81

1.26 ± 1.07

24

0.54 ± 0.82

.0033

27

1.33 ± 1.22

23

0.60 ± 0.70

.0114

TS

Year 1

145

0.56 ± 0.40

101

0.25 ± 0.36

.0001

 

Year 2

107

0.84 ± 0.54

66

0.63 ± 0.56

.0168

SGA

Year 1

101

0.82 ± 0.53

30

0.27 ± 0.28

.0001

52

0.58 ± 0.55

25

0.41 ± 0.35

.0931

 

Year 2

63

1.23 ± 0.60

14

0.59 ± 0.51

.0005

29

1.00 ± 0.74

13

0.87 ± 0.51

.5670

NS

Year 1

18

0.53 ± 0.41

12

0.16 ± 0.38

.0212

6

0.31 ± 0.45

5

0.26 ± 0.47

.8565

 

Year 2

10

0.83 ± 0.84

5

0.25 ± 0.45

.1763

1

0.23 ± —

1

0.10 ± —

ISS

Year 1

115

0.60 ± 0.44

208

0.38 ± 0.29

.0001

47

0.71 ± 0.37

92

0.35 ± 0.38

.0001

 

Year 2

83

0.96 ± 0.63

110

0.79 ± 0.51

.0400

33

1.25 ± 0.61

48

0.73 ± 0.62

.0004

  1. values are for comparisons between age groups for each year
  2. GHD: isolated/idiopathic growth hormone deficiency; MPHD: multiple pituitary hormone deficiency; TS: Turner syndrome; SGA: short for gestational age; NS: Noonan syndrome; ISS: idiopathic short stature.